ANT2 expression under hypoxic conditions produces opposite cell-cycle behavior in 143B and HepG2 cancer cells

Molecular Carcinogenesis

Volumn 42, Issue 1, 2005, Pages 1-8

  Chevrollier, Arnaud ^a   Loiseau, Dominique ^a   Gautier, Fabien ^a   Malthièry, Yves ^a   Stepien, Georges ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

ANT2; Cancer; Glycolysis; Hypoxia; Mitochondria

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYTOPLASMIC ADENOSINE TRIPHOSPHATE; GLUCOSE; LACTIC ACID; MITOCHONDRIAL ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANT2 GENE; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL METABOLISM; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL TRANSFORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GLYCOLYSIS; HK II GENE; HUMAN; HUMAN CELL; HYPOXIA; MEMBRANE POTENTIAL; MITOCHONDRIAL INTEGRITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TRANSPORT; STRESS; VEGF GENE;

ADENINE NUCLEOTIDE TRANSLOCATOR 2; ADENINE NUCLEOTIDE TRANSLOCATOR 3; ANOXIA; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; HEXOKINASE; HUMANS; LACTIC ACID; NEOPLASMS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

FORMICIDAE;

EID: 11144350253     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20059     Document Type: Article

References (43)

1. Klingenberg M. The ADP-ATP translocation in mitochondria, a membrane potential controlled transport. J Membr Biol 1980;56:97-105.
2. Stepien G, Torroni A, Chung A, Hodge JA, Wallace DC. Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during cell differentiation. J Biol Chem 1992; 14592-14597.
3. Baggetto LG. Deviant energetic metabolism of glycolytic cancer cells. Biochimie 1992;74:959-974.
4. Mazurek S, Eigenbrodt E, Failing K, Steinberg P. Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells. J Cell Physiol 1999;181: 136-146.
5. Carew JS, Huang P. Mitochondrial defects in cancer. Mol Cancer 2002;1:9.
6. Wallace DC. Mouse models for mitochondrial disease. Am J Med Genet 2001;106:71-93.
7. Lemasters JJ, Nieminen AL, Qian T, et al. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1998;1366:177-196.
8. Giraud S, Bonod-Bidaud C, Wesolowski-Louvel M, Stepien G. Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J Mol Biol 1998;281:409-418.
9. Amiri H, Karlberg O, Andersson SE. Deep origin of plastid/parasite ATP/ADP translocases. J Mol Evol 2003;56:137-150.
10. Sabova L, Zeman I, Supek F, Kolarov J. Transcriptional control of AAC3 gene encoding mitochondrial ADP/ATP translocator in Saccharomyces cerevisiae by oxygen, heme and ROX1 factor. Eur J Biochem 1993;213:547-553.
11. Sokolikova B, Sabova L, Kissova I, Kolarov J. A carbon-source-responsive element is required for regulation of the hypoxic ADP/ATP carrier (AAC3) isoform in Saccharomyces cerevisiae. Biochem J 2000;352(Pt. 3):893-898.
12. Acker T, Plate KH. A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology. J Mol Med 2002; 80:562-575.
13. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000;97:9082-9087.
14. Lal A, Peters H, St Croix B, et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 2001;93:1337-1343.
15. Seagroves TN, Ryan HE, Lu H, et al. Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol 2001;21:3436-3444.
16. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995;92: 5510-5514.
17. Semenza GL. HIF-1 and tumor progression: Pathophysiology and therapeutics. Trends Mol Med 2002;8:S62-S67.
18. Harris AL. Hypoxia - A key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47.
19. Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271-275.
20. Akakura N, Kobayashi M, Horiuchi I, et al. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 2001;61:6548-6554.
21. Dachs GU, Tozer GM. Hypoxia modulated gene expression: Angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer 2000;36:1649-1660.
22. Chen J, Gamou S, Takayanagi A, Ohtake Y, Ohtsubo M, Shimizu N. Targeted in vivo delivery of therapeutic gene into experimental squamous cell carcinomas using anti-epidermal growth factor receptor antibody: immunogene approach. Hum Gene Ther 1998;9:2673-2681.
23. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980;209:497-499.
24. Loiseau D, Chevrollier A, Douay O, et al. Oxygen consumption and expression of the adenine nucleotide translocator in cells lacking mitochondrial DNA. Exp Cell Res 2002;278: 12-18.
25. Simpson DA, Feeney S, Boyle C, Stitt AW. Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR. Mol Vis 2000;6:178-183.
26. Panneels V, Schussler U, Costagliola S, Sinning I. Choline head groups stabilize the matrix loop regions of the ATP/ADP carrier ScAAC2. Biochem Biophys Res Commun 2003;300: 65-74.
27. Larm JA, Vaillant F, Linnane AW, Lawen A. Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa rho 0 cells. J Biol Chem 1994; 269:30097-40100.
28. McClintock DS, Santore MT, Lee VY, et al. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol 2002; 22:94-104.
29. Beltran B, Mathur A, Duchen MR, Erusalimsky JD, Moncada S. The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. Proc Natl Acad Sci USA 2000;97:14602-14607.
30. Almeida A, Almeida J, Bolanos JP, Moncada S. Different responses of astrocytes and neurons to nitric oxide: The role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci USA 2001;98:15294-15299.
31. Appleby RD, Porteous WK, Hughes G, et al. Quantitation and origin of the mitochondrial membrane potential in human cells lacking mitochondrial DNA. Eur J Biochem 1999;262: 108-116.
32. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68-72.
33. Bae MK, Kwon YW, Kim MS, et al. Identification of genes differentially expressed by hypoxia in hepatocellular carcinoma cells. Biochem Biophys Res Commun 1998;243: 158-162.
34. Kishi T, Morre DM, Morre DJ. The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity. Biochim Biophys Acta 1999;1412:66-77.
35. Boutilier RG, St-Pierre J. Surviving hypoxia without really dying. Comp Biochem Physiol A Mol Integr Physiol 2000; 126:481-490.
36. King MP, Attardi G. Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation. Science 1989;246:500-503.
37. Ara G, Kusumoto T, Korbut TT, Cullere-Luengo F, Teicher BA. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: Evidence for mitochondrial involvement. Cancer Res 1994;54:1497-1502.
38. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ, Jr., Giaccia AJ. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 1994;14:6264-6277.
39. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998;394:485-490.
40. Chandel NS, Vander Heiden MG, Thompson CB, Schumacker PT. Redox regulation of p53 during hypoxia. Oncogene 2000;19:3840-3848.
41. Arnould T, Vankoningsloo S, Renard P, et al. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. Embo J 2002;21: 53-63.
42. Beroud C, Soussi T. p53 gene mutation: Software and database. Nucleic Acids Res 1998;26:200-204.
43. Salnikow K, Costa M, Figg WD, Blagosklonny MV. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res 2000;60:5630-5634.